Lysiac is specialized and experienced in access to treatment and market access, reimbursement, HTA, the “lock”, negotiations, finance, budgets, tariffs, health economics and appraisal. Lysiac has detailed knowledge and can give you insightful overviews at the same time, for example on the intramural and extramural system, the general principles for reimbursement and access for drugs, orphan drugs, biotech products, ATMPs, diagnostics and medical devices. Lysiac is working on the development of these policies as well as on the implementation in practice.
Examples of how the experience of Lysiac can be deployed are strategic advice, analysis of developing policies, seminars, (tailored) training, reimbursement dossiers, advisory boards and expert documents. By providing relevant information, strategic insight, public affairs support and network Lysiac helps in being successful based on common goals with other stakeholders.
Lysiac is committed to contributing to better alignment of healthcare practice and policy, from a broad societal perspective. To achieve this, Lysiac provides strategic insights into (developing) policies and their application in practice, tailored to your organization.
Lysiac works with local specialized partners in Europe for coordinated pan-European projects and/or local expertise in the individual countries.